Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis

NANot yet recruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2027

Conditions
Arthritis, Rheumatoid
Interventions
BEHAVIORAL

Rheumatoid arthritis educational booklet

Participants will receive a low-literacy rheumatoid arthritis educational booklet that provides general disease state information.

BEHAVIORAL

Multidisciplinary rheumatologic care

At each regularly scheduled clinic appointment, participants will receive treatment from their assigned rheumatologist, undergo an in-clinic physical therapy evaluation and, if indicated, a psychological evaluation. Physical therapy and psychology follow-up sessions will occur as directed by the individual services.

BEHAVIORAL

Nurse education and monthly calls

Participants will meet one-on-one with a rheumatology nurse for a tailored educational session encompassing disease state education, an introduction of the treat to target concept, an overview of treatment options, and goal setting and planning. During monthly follow-up calls, participant educational needs will be addressed; goal setting, planning and review will also be conducted.

BEHAVIORAL

Monthly healthcare coordinator calls

During monthly calls with the healthcare coordinator, specific questions and concerns raised by participants may be addressed. The primary purpose of these calls is to control for potential benefit derived from time on the phone with a health professional.

BEHAVIORAL

Technology-based symptom monitoring and reporting

When at home patient self-monitoring reports indicate a significant increase in RA disease activity, participants will be promptly contacted and scheduled for an ad hoc evaluation with their treating rheumatologist.

Trial Locations (1)

90502

The Lundquist Institute at Harbor-UCLA Medical Center, Torrance

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

OTHER

NCT02720874 - Multidisciplinary Approach for Treat To Target In Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter